Archives

Wegovy® pill demonstrated greater weight loss than orforglipron and lower odds of stopping medication due to side effects in a new indirect comparison to be presented at Obesity Medicine Association 2026

B Oral semaglutide 25 mg demonstrated significantly greater mean weight loss than orforglipron 36 mg in a population-adjusted indirect treatment comparison (ITC) using data from… Login to continue reading Login…

Read MoreWegovy® pill demonstrated greater weight loss than orforglipron and lower odds of stopping medication due to side effects in a new indirect comparison to be presented at Obesity Medicine Association 2026

Cambridge Global Advisors Awarded Grant to Build Cyber Capacity Among Women in the Pacific from Australia’s Department of Foreign Affairs and Trade

B WASHINGTON, April 2, 2026 /PRNewswire/ — Australia’s Department of Foreign Affairs and Trade (DFAT) has partnered with Cambridge Global Advisors (CGA) to implement a… Login to continue reading Login…

Read MoreCambridge Global Advisors Awarded Grant to Build Cyber Capacity Among Women in the Pacific from Australia’s Department of Foreign Affairs and Trade

Positive Clinical Results from HyBryte™ Comparative Study Evaluating HyBryte™ Against Valchlor® in the Treatment of Cutaneous T-Cell Lymphoma Published in Oncology and Therapy

B HyBryte™ demonstrates more rapid and robust treatment response compared to Valchlor® during 12-week treatment course PRINCETON, N.J., April 2, 2026 /PRNewswire/ — Soligenix, Inc. (Nasdaq:… Login to continue reading Login…

Read MorePositive Clinical Results from HyBryte™ Comparative Study Evaluating HyBryte™ Against Valchlor® in the Treatment of Cutaneous T-Cell Lymphoma Published in Oncology and Therapy